The congenital Valsalva sinus aneurysm is a rare cardiac malformation characterized by abnormal dilation of the Valsalva sinus, an area of the aorta located at the origin of the coronary arteries. When an aneurysm forms in this region, it may result in a pathological communication between the aneurysm and the aorta, creating an aortic fistula. This defect generates a left-to-right shunt, leading to volume overload in the left cardiac chambers and pulmonary hypertension if left untreated.
Early surgical intervention is critical to prevent severe complications such as congestive heart failure, arrhythmias, and left ventricular dysfunction. The condition is often associated with other congenital heart defects, including ventricular septal defect (VSD) and atrial septal defect (ASD), which further complicate therapeutic management.
Valsalva sinus aneurysm can be congenital or acquired. The congenital form, which is rarer, results from a developmental defect in the formation of the sinus walls during fetal life. Normally, the walls of the sinuses of Valsalva should develop into well-defined, solid structures. In some cases, defects in muscle tissue or connective tissue lead to weakness in the vessel wall and subsequent aneurysm formation.
Congenital aneurysms may be isolated or associated with other defects such as:
In acquired cases, aneurysms may result from trauma, infections (particularly infective endocarditis), or previous cardiac surgeries. However, congenital forms represent the majority of Valsalva sinus aneurysms with aortic fistula.
The pathogenesis of congenital Valsalva sinus aneurysm involves abnormal dilation where the sinus connects with the aorta. If the aneurysm grows large enough, it can form a fistulous connection between the sinus and the aortic cavity. This leads to an abnormal left-to-right blood flow, increasing the volume load on the heart.
Initially, compensatory mechanisms maintain cardiac function, but over time, the persistent shunt results in:
If untreated, persistent pulmonary hypertension may lead to the development of Eisenmenger syndrome, characterized by shunt reversal, cyanosis, and serious respiratory complications. Left-sided heart failure may also ensue, further compromising cardiac function.
Congenital Valsalva sinus aneurysm with aortic fistula is a rare condition, and its precise cause remains largely unknown. However, several risk factors can increase the likelihood of its occurrence.
Main predisposing factors include:
Since this malformation is congenital, there are no specific preventive measures. However, good maternal health during pregnancy, prevention of infections, vaccination, and lifestyle optimization can help reduce the general risk of congenital anomalies.
Symptoms of congenital Valsalva sinus aneurysm with aortic fistula vary depending on the aneurysm size and shunt severity. Mild cases may remain asymptomatic for years and are often discovered incidentally. In more significant cases, symptoms typically manifest in childhood or early adulthood and progress over time.
Key symptoms include:
In pediatric patients, delayed growth and poor weight gain may occur, reflecting the increased metabolic demand imposed by a chronically stressed heart.
During physical examination, the following signs may be present:
Physical examination findings provide important clues for suspecting the diagnosis and initiating targeted diagnostic investigations.
Clinical suspicion arises in the presence of unexplained heart failure signs, continuous murmurs, and symptoms like palpitations, dyspnea, and exercise intolerance, particularly in young patients. Prompt recognition is essential to avoid progression to irreversible complications.
Transthoracic echocardiography (TTE) is the first-line diagnostic tool. It can identify the aneurysm and visualize the abnormal communication between the Valsalva sinus and the aorta. Color Doppler imaging evaluates the shunt flow, chamber dilation, and ventricular function.
Transesophageal echocardiography (TEE) may be necessary when TTE images are suboptimal or for preoperative planning.
Cardiac magnetic resonance imaging (MRI) provides detailed information on the size, location, and hemodynamic impact of the aneurysm and fistula. It is especially useful for complex cases or surgical planning.
Cardiac catheterization is rarely required but may be indicated to measure pulmonary pressures and assess shunt severity, especially if pulmonary hypertension is suspected.
The treatment of congenital Valsalva sinus aneurysm with aortic fistula depends on the severity of the condition, the size of the aneurysm, and the presence of hemodynamic complications. Because the defect can cause significant left ventricular overload and/or pulmonary hypertension, timely intervention is crucial to prevent permanent damage to the heart and lungs.
Therapeutic options include:
Open-heart surgery is the treatment of choice for significant cases of Valsalva sinus aneurysm with aortic fistula. The procedure involves resecting the aneurysm and closing the fistula between the sinus and the aorta. Surgery is typically performed under cardiopulmonary bypass, through a thoracotomy or, in complex cases, via endoscopic approaches. The goal is to restore normal anatomy and blood flow, thus preventing heart failure and pulmonary complications.
In extensive aneurysms involving a large portion of the sinus, synthetic or biological patches may be needed to repair the defect and reinforce the aortic wall.
In selected patients, especially those with small and well-defined aneurysms, percutaneous closure may be considered. This minimally invasive procedure involves accessing the defect through the femoral vein and deploying an occluder device. Percutaneous closure offers advantages such as faster recovery, lower risk of complications, and minimal invasiveness; however, it is not suitable for all patients, particularly those with large or complex aneurysms.
The prognosis for patients with congenital Valsalva sinus aneurysm with aortic fistula who undergo timely repair is generally excellent. Surgical correction of the aneurysm and closure of the fistula usually normalize cardiac function and pulmonary pressures. Patients treated early can expect survival rates comparable to the general population and a return to a normal quality of life.
In untreated or late-treated patients, the prognosis depends on the extent of hemodynamic complications. Severe, irreversible pulmonary hypertension can lead to Eisenmenger syndrome, making surgical intervention more complex and significantly decreasing life expectancy. In such cases, management focuses on improving quality of life rather than curative treatment.
The main complications associated with untreated congenital Valsalva sinus aneurysm with aortic fistula include:
Prompt surgical repair significantly reduces the risk of these complications and greatly improves both prognosis and long-term quality of life.